Daniela Schloesser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniela Schloesser has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Julia Sauer
Immunology & Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany
2 shared publications - Carolin Kirsten Watson
Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
1 shared publication - Eva Griesser
Drug Discovery Sciences Boehringer Ingelheim Pharma GmbH & Co. KG Biberach an der Riß Germany
1 shared publication Florian Gantner
Department of Translational Medicine and Clinical Pharmacology, C. H. Boehringer Sohn AG & Co. KG, 88397 Biberach an der Riss, Germany
1 shared publication- Frederik H. Igney
Boehringer Ingelheim Pharma GmbH & Co. KG Discovery Research
1 shared publication - Heiko Olbrich
Interfakultäres Institut für Biochemie, Universität Tübingen, Deutschland
1 shared publication
Latest Publications
- Open Access
- 16 April 2023
- Published by Elsevier in SLAS Discovery
- Vol. 28 (4) , 149-162
Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay
- 16 April 2023
- Published by Elsevier in SLAS Discovery
- Vol. 28 (4) , 149-162
Open AccessApplication of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay
- Open Access
- 2 December 2022
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 222 (2)
Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
Progressive accrual of senescent cells in aging and chronic diseases is associated with detrimental effects in tissue homeostasis. We found that senescent fibroblasts and epithelia were not only refractory to macrophage-mediated engulfment and removal, but they also paralyzed the ability of macrophages to remove bystander apoptotic corpses. Senescent cell-mediated efferocytosis suppression (SCES) was independent of the senescence-associated secretory phenotype (SASP) but instead required direct contact between macrophages and senescent cells. SCES involved augmented senescent cell expression of CD47 coinciding with increased CD47-modifying enzymes QPCT/L. SCES was reversible by interfering with the SIRPα-CD47-SHP-1 axis or QPCT/L activity. While CD47 expression increased in human and mouse senescent cells in vitro and in vivo, another ITIM-containing protein, CD24, contributed to SCES specifically in human epithelial senescent cells where it compensated for genetic deficiency in CD47. Thus, CD47 and CD24 link the pathogenic effects of senescent cells to homeostatic macrophage functions, such as efferocytosis, which we hypothesize must occur efficiently to maintain tissue homeostasis.
- 2 December 2022
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 222 (2)
Open AccessSenescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
Progressive accrual of senescent cells in aging and chronic diseases is associated with detrimental effects in tissue homeostasis. We found that senescent fibroblasts and epithelia were not only refractory to macrophage-mediated engulfment and removal, but they also paralyzed the ability of macrophages to remove bystander apoptotic corpses. Senescent cell-mediated efferocytosis suppression (SCES) was independent of the senescence-associated secretory phenotype (SASP) but instead required direct contact between macrophages and senescent cells. SCES involved augmented senescent cell expression of CD47 coinciding with increased CD47-modifying enzymes QPCT/L. SCES was reversible by interfering with the SIRPα-CD47-SHP-1 axis or QPCT/L activity. While CD47 expression increased in human and mouse senescent cells in vitro and in vivo, another ITIM-containing protein, CD24, contributed to SCES specifically in human epithelial senescent cells where it compensated for genetic deficiency in CD47. Thus, CD47 and CD24 link the pathogenic effects of senescent cells to homeostatic macrophage functions, such as efferocytosis, which we hypothesize must occur efficiently to maintain tissue homeostasis.